CPRiL

C25H28ClN5O5S2

CC1=C(C=C(S1)C(=O)C2=CN=CN=C2N[C@@H]3C[C@@H]([C@H](C3)O)COS(=O)(=O)N)[C@H]4C5=C(CCN4)C=CC(=C5)Cl

InChI=1S/C25H28ClN5O5S2/c1-13-18(23-19-7-16(26)3-2-14(19)4-5-29-23)9-22(37-13)24(33)20-10-28-12-30-25(20)31-17-6-15(21(32)8-17)11-36-38(27,34)35/h2-3,7,9-10,12,15,17,21,23,29,32H,4-6,8,11H2,1H3,(H2,27,34,35)(H,28,30,31)/t15-,17-,21+,23+/m1/s1

• Subasumstat
• TAK-981
• Subasumstat [USAN]
XQ43H3V6M1
UNII-XQ43H3V6M1
SUBASUMSTAT [INN]
subasumstat (proposed INN)
SUBASUMSTAT [WHO-DD]
[(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate
Example 133 [WO2016004136A1]
I-263a [WO2016004136A1]
[(1R,2S,4R)-4-[(5-[4-[(1R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl)amino]-2-hydroxycyclopentyl]methyl sulfamate
SULFAMIC ACID, ((1R,2S,4R)-4-((5-((4-((1R)-7-CHLORO-1,2,3,4-TETRAHYDRO-1-ISOQUINOLINYL)-5-METHYL-2-THIENYL)CARBONYL)-4-PYRIMIDINYL)AMINO)-2-HYDROXYCYCLOPENTYL)METHYL ESTER
Example 133 (WO2016004136A1)
I-263a (WO2016004136A1)
((1R,2S,4R)-4-((5-(4-((1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)-5-methylthiophene-2-carbonyl)pyrimidin-4-yl)amino)-2-hydroxycyclopentyl)methyl sulfamate
TAK 981
1858276-04-6
Sumoylation inhibitor TAK-981
[(1R,2S,4R)-4-[[5-[[4-((1R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)-5-methylthien-2-yl]carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate
TAK981
((1R,2S,4R)-4-((5-(4-((R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)-5-methylthiophene-2-carbonyl)pyrimidin-4-yl)amino)-2-hydroxycyclopentyl)methyl sulfamate
WHO 11858
1858276-04-6 (free)
TAK-981 oxalate
((1R,2S,4R)-4-((5-((4-((1R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)-5-methylthien-2-yl)carbonyl)pyrimidin-4-yl)amino)-2-hydroxycyclopentyl)methyl sulfamate
TAK981 oxalate
Subasumstat (USAN/INN)
CHEMBL4862901
SCHEMBL17398333